Fmr LLC Blueprint Medicines Corp Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fmr LLC holds 558,960 shares of BPMC stock, worth $72.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

558,960

Previous 1,433,169 61.0%

Holding current value

$72.4 Million

Previous $127 Million 43.52%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$79.22 - $128.4 $69.3 Million - $112 Million	-874,209 Reduced 61.0%	558,960 $71.6 Million
Q1 2025 May 12, 2025	SELL	$86.69 - $115.63 $70.6 Million - $94.2 Million	-814,510 Reduced 36.24%	1,433,169 $127 Million
Q4 2024 Feb 13, 2025	SELL	$82.48 - $101.39 $187 Million - $230 Million	-2,269,092 Reduced 50.24%	2,247,679 $196 Million
Q3 2024 Nov 13, 2024	SELL	$84.1 - $120.5 $26.7 Million - $38.2 Million	-316,913 Reduced 6.56%	4,516,771 $418 Million
Q2 2024 Aug 13, 2024	SELL	$85.18 - $108.78 $28.6 Million - $36.5 Million	-335,833 Reduced 6.5%	4,833,684 $521 Million
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $60.1 Million - $81.9 Million	821,206 Added 18.89%	5,169,517 $490 Million
Q4 2023 Feb 13, 2024	SELL	$43.96 - $92.84 $76.4 Million - $161 Million	-1,736,944 Reduced 28.54%	4,348,311 $401 Million
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $29.2 Million - $41.1 Million	-622,882 Reduced 9.29%	6,085,255 $306 Million
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $89.2 Million - $140 Million	-2,113,985 Reduced 23.96%	6,708,137 $424 Million
Q1 2023 May 11, 2023	SELL	$37.97 - $50.0 $5.79 Million - $7.62 Million	-152,423 Reduced 1.7%	8,822,122 $397 Million
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $682,376 - $1.1 Million	16,619 Added 0.19%	8,974,545 $393 Million
Q3 2022 Nov 10, 2022	BUY	$49.93 - $77.7 $19.1 Million - $29.7 Million	381,847 Added 4.45%	8,957,926 $590 Million
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $147 Million - $227 Million	3,242,698 Added 60.8%	8,576,079 $433 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $161 Million - $329 Million	2,984,929 Added 127.1%	5,333,381 $341 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $81.4 Million - $100 Million	-863,512 Reduced 26.88%	2,348,452 $252 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $84.1 Million - $114 Million	-1,038,167 Reduced 24.43%	3,211,964 $330 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $352 Million - $429 Million	4,250,131 New	4,250,131 $374 Million

Others Institutions Holding BPMC

# of Institutions

390

Shares Held

66.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account